Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan

Mostrar otras versiones (1)

A 51-year-old man who had been receiving steroid therapy for type 1 autoimmune pancreatitis (AIP) for 3 years contracted coronavirus disease 2019 (COVID-19). As he had a high-grade fever and dry cough, and because his SpO(2) level had dropped below 95% in the supine position, he was considered as be...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsuso, Chihiro, Kubota, Kensuke, Tanaka, Katsushi, kurita, Yusuke, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332964/
https://www.ncbi.nlm.nih.gov/pubmed/37316279
http://dx.doi.org/10.2169/internalmedicine.1421-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332964/
https://www.ncbi.nlm.nih.gov/pubmed/37316279
http://dx.doi.org/10.2169/internalmedicine.1421-22

Ejemplares similares